Progestágenos para el tratamiento de la amenaza de aborto espontáneo
Información
- DOI:
- https://doi.org/10.1002/14651858.CD005943.pub4Copiar DOI
- Base de datos:
-
- Cochrane Database of Systematic Reviews
- Versión publicada:
-
- 07 diciembre 2011see what's new
- Tipo:
-
- Intervention
- Etapa:
-
- Review
- Grupo Editorial Cochrane:
-
Grupo Cochrane de Embarazo y parto
- Copyright:
-
- Copyright © 2011 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Cifras del artículo
Altmetric:
Citado por:
Autores
Contributions of authors
For the 2011 update, Dr Hayfaa Wahabi participated in the selection of eligible studies and assessment of the studies for inclusion. She wrote both the initial and final version of the review. Dr Amel Fayed, Dr Samia Ahmed, and Dr Rasmieh Al‐Zeidan participated in the data extraction and the assessment of the studies for inclusion in the review and reviewed and approved the final version of the review.
Sources of support
Internal sources
-
Cochrane Review Initiative Project, Saudi Arabia.
External sources
-
No sources of support supplied
Declarations of interest
None known.
Acknowledgements
We acknowledge the help of Ms Lusia Bartos, Ms Maria Wong, and Ms Gillian Pei Yoong Lim for translating reports of trials in languages other than English.
Thanks to Nuha F Abed Althagafi and Mamoun Elawad for their contribution to the protocol and the initial version of this review.
As part of the pre‐publication editorial process, this review has been commented on by three peers (an editor and two referees who are external to the editorial team), a member of the Pregnancy and Childbirth Group's international panel of consumers and the Group's Statistical Adviser.
Version history
| Published | Title | Stage | Authors | Version |
| 2018 Aug 06 | Progestogen for treating threatened miscarriage | Review | Hayfaa A Wahabi, Amel A Fayed, Samia A Esmaeil, Khawater Hassan Bahkali | |
| 2011 Dec 07 | Progestogen for treating threatened miscarriage | Review | Hayfaa A Wahabi, Amel A Fayed, Samia A Esmaeil, Rasmieh A Al Zeidan | |
| 2011 Mar 16 | Progestogen for treating threatened miscarriage | Review | Hayfaa A Wahabi, Nuha F Abed Althagafi, Mamoun Elawad, Rasmieh A Al Zeidan | |
| 2007 Jul 18 | Progestogen for treating threatened miscarriage | Review | Hayfaa A Wahabi, Nuha F Abed Althagafi, Mamoun Elawad, Rasmieh A Al Zeidan | |
| 2006 Apr 19 | Progestogen for treating threatened miscarriage | Protocol | Hayfaa A Wahabi, Nuha F Abed, Mamoun Elawad | |
Differences between protocol and review
The primary outcome 'Miscarriage', was previously listed as 'Early miscarriage up to 12 weeks' and 'Miscarriage later than 12 weeks and less than 23 weeks'.
The methods have been updated to reflect the latest Cochrane Handbook (Higgins 2011)
